| Entry |
|
|---|
| Name |
Tiletamine (INN) |
|---|
| Formula |
C12H17NOS
|
|---|
| Exact mass |
223.1031
|
|---|
| Mol weight |
223.3345
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Anticonvulsant, Anesthetic |
|---|
| Comment |
Phencyclidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
DG01380 Tiletamine
D08596 Tiletamine
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D08596 Tiletamine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
DG01380 Tiletamine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 15
1 C1x C 21.2800 -17.7800
2 C1x C 21.2800 -19.1800
3 C1x C 22.4700 -19.8800
4 C1x C 23.7300 -19.1800
5 C1z C 23.7300 -17.7800
6 C5x C 22.4700 -17.0800
7 C8y C 24.9200 -17.0800
8 C8x C 26.2500 -17.5000
9 C8x C 27.0900 -16.3800
10 C8x C 26.2500 -15.2600
11 S2x S 24.9200 -15.6800
12 N1b N 24.9200 -18.4800
13 C1b C 24.9200 -19.8800
14 C1a C 26.1100 -20.6500
15 O5x O 22.4700 -15.6800
BOND 16
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 7 11 1
13 5 12 1
14 12 13 1
15 13 14 1
16 6 15 2
|
|---|
